Are you a nonprofit research organization and want to access KeyGene’s intellectual property in a quick and easy way to make use of our innovative technologies? Here we offer you information and opportunities for licensing.
Looking for a technology for simultaneously discovery and scoring of genetic markers without genome sequence information in a cost-effective way? Use KeyGene’s Sequence-Based Genotyping! Here you can obtain a license for using the SBG technology for research purposes. Download the form, fill in the required details and the return the form to our expert Michiel van Eijk. After payment of the licensing fee you will obtain the license. There is a licensing form for US and non-US nonprofit research organizations.
If you are interested in a tailor-made licensing proposal for the commercial application of SBG we advise you to contact our expert.
KeyGene’s SBG technology is protected by a global dominant patent portfolio (more information in this press release). This portfolio with granted and pending patents protects methods known as SBG, GBS, two-enzyme GBS, tunable GBS, RAD, ddRAD, 2b-RAD, SLAF-seq and related methods using restriction enzyme digestion and/or amplicon sequencing to produce complexity-reduced genome fractions sequenced with next-generation sequencing platforms.
The following nonprofit research organizations have gained access to the SBG technology for research purposes:
– The James Hutton Institute
– University of Hohenheim
– University of Zürich
– University of Edinburgh
– Forschungszentrum Jülich
– Wageningen University
Licensees United States:
– University of Minnesota Genomics Center
– South Dakota State University
– Oregon State University
– Tennessee Technological University
– Samuel Roberts Noble Foundation
– San Diego Zoo Global
– North Carolina State University